Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Bausch + Lomb’s IPO plans come into focus as BHC prepares to split into three
MedCity News
Sun, 01/16/22 - 03:47 am
Bausch Health
IPOs
As three biotechs head to Wall Street, a battered sector braces for a pullback
BioPharma Dive
Fri, 01/7/22 - 10:34 am
Amylyx
CinCor
Vigil Neuroscience
IPOs
biotech
Gene therapy player Affinia aims to go public, hoping to raise big money in effort to remake AAVs
Endpoints
Wed, 01/5/22 - 10:37 am
Affinia Therapeutics
IPOs
gene therapy
funding
Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs
MedCity News
Fri, 12/31/21 - 11:04 am
IPOs
cell therapy
artificial intelligence
Sana Biotechnology
Lyell Immunopharma
Caribou Biosciences
Instil Bio
Talaris Therapeutics
Achilles Therapeutics
Italian cancer gene therapy biotech makes history with modest Nasdaq IPO
Endpoints
Thu, 12/16/21 - 11:08 am
gene therapy
IPOs
NASDAQ
Genenta
Italy
Biotech Companies Launch or Plan IPOs: Vaxxinity, Genenta and Enetrada
BioSpace
Thu, 11/11/21 - 11:26 pm
IPOs
Vaxxinity
Genenta Science
Enetrada
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Fierce Biotech
Thu, 11/11/21 - 11:03 am
Vaxxinity
IPOs
vaccines
immunotherapy
NASDAQ
Gyroscope spins the wheel again as it taps Sanofi for $60M months after ditching IPO attempt
Fierce Biotech
Mon, 11/8/21 - 10:51 am
IPOs
Gyroscope Therapeutics
Sanofi
First Day Trading a Letdown for LianBio in Shadow of Beijing Market Crackdown
BioSpace
Tue, 11/2/21 - 11:42 pm
LianBio
Beijing
IPOs
NASDAQ
Ventyx nabs a $152M upsized IPO to challenge BMS' Zeposia—and a backer with intimate knowledge of its rival
Fierce Biotech
Fri, 10/22/21 - 12:04 pm
Ventyx Biosciences
IPOs
autoimmune disease
Bristol Myers Squibb
Zeposia
Xilio Therapeutics goes public as biopharma IPOs rumble forward in Q4
Endpoints
Fri, 10/22/21 - 12:02 pm
Xilio Therapeutics
IPOs
solid tumors
Two Biopharmas Nix IPO Plans in Unstable Market
BioSpace
Thu, 10/21/21 - 11:18 pm
NASDAQ
IPOs
AEON Biopharma
Cingulate
IPO floodgates open up after summer lull as five more biotechs file for Nasdaq
Endpoints
Tue, 10/12/21 - 10:59 am
Evotec
Entrada Therapeutics
Aura Biosciences
Vaxxinity
Blue Water Vaccines
IPOs
Pfizer, Bayer-backed Pyxis ups IPO price as biotech's public run continues unabated
Fierce Biotech
Fri, 10/8/21 - 10:39 am
IPOs
Pyxis Oncology
Pfizer
Bayer
oncology
OrbiMed's TKI play makes its Nasdaq debut as Theseus prices IPO
Endpoints
Thu, 10/7/21 - 11:13 am
IPOs
Theseus Pharmaceuticals
OrbiMed
NASDAQ
Biotech listings show signs of a slowdown
EP Vantage
Wed, 10/6/21 - 10:38 am
IPOs
Adagio Therapeutics
Caribou Biosciences
Erasca
DiCE Therapeutics
Icosavax
This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More
Motley Fool, clinical trials,
Mon, 10/4/21 - 10:37 am
IPOs
drug delivery
Rani Therapeutics
The cash won't stop for Exscientia as it makes a $300M+ Nasdaq debut
Endpoints
Sun, 10/3/21 - 08:16 pm
Exscientia
IPOs
artificial intelligence
Covid has made biotech companies the hot new tech sector as investor demand drives record IPOs
CNBC
Fri, 10/1/21 - 10:42 am
biotech
IPOs
investors
A New Medtech IPO Could Be on the Way
Medical Devices and Diagnostics Industry
Tue, 09/28/21 - 12:03 am
Medtech
diagnostics
IPOs
PaveMed
spinoffs
Lucid Diagnostics
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »